The Tokyo-based startup company, has developed glucose-modified polymeric micelles that interact with glucose transporter 1 (GLUT1) and thus allow to transport drugs through the BBB to the brain.

Braizon Therapeutics URL http://www.braizon.com/en/technology/index.html